Copyright
©2010 Baishideng.
World J Gastroenterol. Aug 7, 2010; 16(29): 3709-3715
Published online Aug 7, 2010. doi: 10.3748/wjg.v16.i29.3709
Published online Aug 7, 2010. doi: 10.3748/wjg.v16.i29.3709
Table 2 Recurrence-free survival and overall survival analysis
| Variable | Categories/units | n | HR (95% CI) | P-value |
| Recurrence-free survival | ||||
| Treatment | XRT | 108 | 1 | |
| 5FU-RT | 1.00 (0.508-1.959) | 1.0 | ||
| Chemo only | 1.05 (0.448-2.462) | 0.9 | ||
| Treatment | XRT | 108 | 1 | |
| 5FU-RT | 0.971 (0.477-1.966) | 0.9 | ||
| Chemo only | 1.031 (0.433-2.444) | 0.9 | ||
| Overall survival | ||||
| Treatment | XRT | 108 | 1 | |
| 5FU-RT | 0.83 (0.411-1.681) | 0.6 | ||
| Chemo only | 1.13 (0.474-2.677) | 0.8 | ||
| Treatment | XRT | 108 | 1 | |
| 5FU-RT | 0.891 (0.428-1.856) | 0.8 | ||
| Chemo only | 1.191 (0.494-2.882) | 0.7 | ||
- Citation: Tham CK, Choo SP, Poon DYH, Toh HC, Ong SYK, Tan SH, Wang MLC, Foo KF. Capecitabine with radiation is an effective adjuvant therapy in gastric cancers. World J Gastroenterol 2010; 16(29): 3709-3715
- URL: https://www.wjgnet.com/1007-9327/full/v16/i29/3709.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i29.3709